CNR Institutional Research Information System

PINNA, ANNALISA

PINNA, ANNALISA  

Istituto di Neuroscienze - IN -  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.02 secondi).
Titolo Data di pubblicazione Autore(i) File
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 1-gen-2021 Simola, Nicola; Pinna, Annalisa; Frau, Lucia; Costa, Giulia; Marongiu, Jacopo; Parekh, Pathik; Serrai, Marcello; Morelli, Micaela Morelli
Control of Motor Function by Adenosine A2A Receptors in Parkinson's and Huntington's Disease 1-gen-2017 Pinna, A; Wardas, J; Domenici, Mr; Popoli, P; Cossu, G; Morelli, M
Farmaci Antiparkinsoniani ed Attivi in altri disturbi motori 1-gen-2016 Pinna, A; Carta, Ar; Corsini, Gu; Morelli, M
Adenosine A2A receptor antagonists as drugs for symptomatic control of parkinson's disease in preclinical studies 1-gen-2015 Pinna, Annalisa; Pinna, Annalisa
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 1-gen-2014 Nicola Simola ; Annalisa Pinna ; Lucia Frau ; Micaela Morelli ;
Symptomatic and neuroprotective effects of A<inf>2A</inf> receptor antagonists in Parkinson's disease 1-gen-2013 Pinna, Annalisa; Simola, Nicola; Frau, Lucia; Morelli, Micaela;
Caffeine consumption and changes in the function of dopaminergic transmission: Evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1-gen-2012 Simola, Nicola; Pinna, Annalisa; Tronci, Elisabetta; Seeman, Philip M.; Morelli, Micaela
FARMACI ANTIPARKINSONIANI ED ATTIVI IN ALTRI DISTURBI MOTORI, vol. 30 del Trattato di Farmacologia 1-gen-2010 Carta A.R.; A. Pinna; G.U. Corsini; A. Caramelli; M. Morelli
Behavioural Correlates of Dopaminergic Agonists' Dyskinetic Potential in the 6-OHDA-Lesioned Rat 1-gen-2009 Carta Anna, R; Frau, L; Pinna, A; Morelli, M
Caffeine consumption and Changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine. Published in Advances in psychology research 1-gen-2009 Simola N; Pinna A; Tronci E; Seeman P; Morelli M.
ADENOSINE A2A RECEPTOR ANTAGONIST TREATMENT OF PARKINSON S DISEASE. In The basal ganglia pathophysiology: recent advances 1-gen-2007 Pinna, A; Simola, N; Morelli, M
CHANGES IN THE EXPRESSION OF TONIC AND PHASIC NEUROCHEMICAL MARKERS OF ACTIVITY IN A RAT MODEL OF L-DOPA INDUCED DYSKINESIA 1-gen-2005 Anna, R CARTA; Pinna, A; E, Tronci; And, M MORELLI
DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSON'S DISEASE 1-gen-2004 N, Simola; Pinna, A; Ar, Carta; E TRONCI AND, M MORELLI
Different patterns of behavior and gene expression induced by chronic L-dopa and A(2A) antagonists plus L-DOPA treatments in 6-hydroxydopamine lesioned rats 1-gen-2002 Carta, Ar; Pinna, A; Morelli, M